UCB is 26th Drugmaker to Exempt Arkansas Providers from Contract Pharmacy Restrictions

UCB exterior sign and building
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions.
Drugmaker UCB recently told 340B providers in Arkansas that it will exempt them from its contract pharmacy restrictions. In a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sandoz Adds Drug to 340B Contract Pharmacy Restrictions

Drugmaker Sandoz updated its 340B contract pharmacy restrictions to include a new medication.
Generic and biosimilar drugmaker Sandoz recently added a drug used in conjunction with cancer treatments to its list of drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bayer Adds Prostate Cancer Drug to Contract Pharmacy Restrictions

Bayer wordmark on building
Bayer added a previously excluded drug to its list of products that face contract pharmacy restrictions.
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

No Adverse Findings in First HRSA Drugmaker Audit of 2024

Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer.
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Contract Pharmacy Restrictions Decision Leaves Unanswered Questions, Ups Pressure for Legislative Action

The D.C. Circuit decided that two drugmakers' current contract pharmacy restrictions were legal, but it left open the possibility that more onerous restrictions may not be.
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Teva Adds 40th Drug to Contract Pharmacy Restriction Policy

Teva added a biosimilar of AbbVie's blockbuster Humira to its list of products included in its 340B contract pharmacy restrictions.
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Appeals Court Approves Drugmakers’ Federal 340B Contract Pharmacy Restrictions But Leaves Open Possibility of Enforcement Against Stricter Policies

A federal appeals court decided that the 340B statute does not prohibit all types of restrictions on 340B contract pharmacy use.
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Minnesota Legislature Clears Contract Pharmacy Access Bill But Enforcement Measures Dropped At Last Moment

The Minnesota legislature passed a bill from state Rep. Dave Lislegard (D) to bar 340B drugmaker contract pharmacy restrictions in the state.
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk To Provide Refunds on Ozempic and Three Other Drugs to 340B Entities

Drugmaker Novo Nordisk is providing refunds to 340B covered entities on its blockbuster diabetes/weight loss drug Ozempic and three other products.
Drugmaker Novo Nordisk announced it is providing 340B covered entities 12-months-worth of refunds on four drug products including two of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Virginia Governor Vetoes 340B Contract Pharmacy Access Law that Nearly Unanimously Passed State Legislature

Virginia Gov. Glenn Youngkin (R) vetoed 340B contract pharmacy access legislation after the state senate rejected his proposed amendment.
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live